Merus Labs International Inc (NASDAQ:MSLI)
| 0.6761 Data as of 3:25pm ET |  +0.0761 / +12.68%Today’s Change | 0.46 Today|||52-Week Range 1.98 | -38.54% Year-to-Date |
Latest MSLI News | Press Releases
No recent news for Merus Labs International Inc.
Today’s Trading
| Previous close | 0.60 |
| Today’s open | 0.68 |
| Day’s range | 0.61 - 0.68 |
| Volume | 16,036 |
| Average volume (3 months) | 9,802 |
| Market cap | $18.4M |
| Dividend yield | -- |
Data as of 3:25pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -85.62% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 0.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DARADARA BioSciences Inc | +0.05 | +7.04% |
| NVGNNovogen Ltd | -0.11 | -2.73% |
| TNXPDTonix Pharmaceutical... | -0.01 | -0.13% |
| TZYMTranzyme Inc | -0.01 | -1.48% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Last reporting date | May 15, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$7.2M |
| Net profit margin | -- |
Profile
Sector Commercial Services |
Industry Advertising/Marketing Services |
President, Chief Executive Officer & Director Elie K. Farah, MBA, CFA |
Chief Financial Officer Andrew Patient |
Corporate headquarters Toronto, Ontario |
Forecasts
